Randomised, Open-label, Crossover study to compare the relative bioavailability of 2 new free-base amorphous solid dispersion formulations (formulation D and E) with the best overencapsulated tablet formulation (formulation C) and to access the effect of a high-fat meal on the PK, safety, and tolerability of mavatrep in Healthy male volunteers
Latest Information Update: 01 Oct 2018
At a glance
- Drugs Mavatrep (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 01 Oct 2018 Results published in the Clinical Pharmacology in Drug Development
- 01 Oct 2018 New trial record